Arshiya Parveen, PhD
Dr. Arshiya Parveen received PhD in Life Sciences at the King Georges Medical University of India, where she investigated the neurotoxicity exerted by silica nanoparticles on dopaminergic and cholinergic systems in rats. In Oct 2018, she joined the Houston Methodist Research Institute as a postdoctoral researcher, where she studied molecular pathways that regulate autophagy in tumor-specific immune memory cells, and how deficiency in autophagy leads to defective mitochondrion accumulation, increased oxidative stress and cell death in these cells. In Nov. 2019 she joined University of Houston where she studied role of ER stress genes in regulating the molecular and signaling mechanisms in skeletal muscle growth, atrophy, regeneration and self-renewal and differentiation of satellite cells in myogenic lineage in adult mice. she joined Dr. Shu Hsia Chen’s group in Oct. 2021 and began working on cancer initiating cells, as well as the immunological changes inside the distinct tumor microenvironment, after administration of radiation therapy, chemotherapy.